1. Home
  2. CRVO vs MPLN Comparison

CRVO vs MPLN Comparison

Compare CRVO & MPLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVO
  • MPLN
  • Stock Information
  • Founded
  • CRVO 2001
  • MPLN 1980
  • Country
  • CRVO United States
  • MPLN United States
  • Employees
  • CRVO N/A
  • MPLN N/A
  • Industry
  • CRVO Biotechnology: Pharmaceutical Preparations
  • MPLN Business Services
  • Sector
  • CRVO Health Care
  • MPLN Consumer Discretionary
  • Exchange
  • CRVO Nasdaq
  • MPLN Nasdaq
  • Market Cap
  • CRVO 98.3M
  • MPLN 113.4M
  • IPO Year
  • CRVO N/A
  • MPLN N/A
  • Fundamental
  • Price
  • CRVO $1.95
  • MPLN $7.14
  • Analyst Decision
  • CRVO Buy
  • MPLN Hold
  • Analyst Count
  • CRVO 8
  • MPLN 2
  • Target Price
  • CRVO $38.75
  • MPLN $25.00
  • AVG Volume (30 Days)
  • CRVO 922.0K
  • MPLN 67.1K
  • Earning Date
  • CRVO 11-12-2024
  • MPLN 11-05-2024
  • Dividend Yield
  • CRVO N/A
  • MPLN N/A
  • EPS Growth
  • CRVO N/A
  • MPLN N/A
  • EPS
  • CRVO N/A
  • MPLN N/A
  • Revenue
  • CRVO $10,066,550.00
  • MPLN $942,614,000.00
  • Revenue This Year
  • CRVO $34.17
  • MPLN N/A
  • Revenue Next Year
  • CRVO N/A
  • MPLN $1.17
  • P/E Ratio
  • CRVO N/A
  • MPLN N/A
  • Revenue Growth
  • CRVO 116.29
  • MPLN N/A
  • 52 Week Low
  • CRVO $1.80
  • MPLN $4.80
  • 52 Week High
  • CRVO $26.38
  • MPLN $69.20
  • Technical
  • Relative Strength Index (RSI)
  • CRVO 24.32
  • MPLN 45.06
  • Support Level
  • CRVO $1.80
  • MPLN $6.80
  • Resistance Level
  • CRVO $2.10
  • MPLN $7.89
  • Average True Range (ATR)
  • CRVO 1.45
  • MPLN 0.67
  • MACD
  • CRVO -0.64
  • MPLN 0.08
  • Stochastic Oscillator
  • CRVO 0.95
  • MPLN 39.53

About CRVO CervoMed Inc.

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

About MPLN MultiPlan Corporation

MultiPlan Corp is a provider of data analytics and technology-enabled solutions designed to bring affordability, efficiency, and fairness to the U.S. healthcare industry. The company interprets clients' needs and customizes solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry.

Share on Social Networks: